Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Mirum Pharmaceuticals Names New Chief Medical Officer

Mirum Pharmaceuticals, Inc. filed a Form 8-K on September 8, 2026, disclosing the appointment of Rob Myers, M.D., as Chief Medical Officer and the planned departure of Joanne Quan, M.D., from that role, effective September 2, 2026.

Shwetambri Chauhan | 08 September 2026

Elmet Group Signs Deal to Acquire OSRAM Tungsten and Molybdenum Assets

The Elmet Group Co. filed a Form 8-K on September 8, 2026, disclosing that its wholly owned subsidiary, Elmet Technologies LLC, entered into an Asset Purchase Agreement on September 3, 2026, to acquire substantially all assets of OSRAM GmbH's metal production operations in Schwabmünchen, …

Vinay Lochav | 08 September 2026

VICI Properties Appoints John M. Sullivan to Board

VICI Properties Inc. filed a Form 8-K on September 8, 2026, announcing the appointment of John M. Sullivan as an independent director to its Board of Directors, effective upon satisfaction of certain conditions including receipt of all applicable regulatory approvals.

Aakashdeep | 08 September 2026

Bitmine Immersion Technologies Terminates Ethereum Staking Management Agreement

Bitmine Immersion Technologies, Inc. filed a Form 8-K on September 8, 2026, disclosing the mutual termination of a Management Services Agreement with Ethereum Tower LLC and the simultaneous entry into a new, simplified services agreement for its Ethereum staking operations.

Vinay Lochav | 08 September 2026

Genpact Names Sumita Pandit as New CFO

Genpact Limited filed an 8-K with the U.S. Securities and Exchange Commission on September 8, 2026, announcing the appointment of Sumita Pandit as Senior Vice President and Chief Financial Officer, effective September 9, 2026, and disclosing the terms of her employment agreement dated September …

Nitish Kishor | 08 September 2026

Sierra Bancorp Discloses Investor Conference Appearance

Sierra Bancorp, a California-incorporated bank holding company traded on the NASDAQ Global Select Market, filed a current report on September 8, 2026, disclosing that senior executives will present at an upcoming investor conference.

Nitish Kishor | 08 September 2026

ASP Isotopes Holds Inaugural Capital Markets Day in London

ASP Isotopes Inc. filed a current report on September 8, 2026, disclosing that the company hosted its first-ever Capital Markets Day in London and released an accompanying investor presentation under Regulation FD.

Aditi Sarkar | 08 September 2026

Roivant Sciences Reports Positive PHocus Trial Results for Mosliciguat

Roivant Sciences Ltd. filed a Form 8-K current report on September 8, 2026, disclosing positive results from the PHocus clinical trial evaluating mosliciguat for the treatment of pulmonary hypertension associated with interstitial lung disease.

Anjali Anand | 08 September 2026

Philip Morris International Files 8-K for Barclays Conference

Philip Morris International Inc. filed a Form 8-K on September 8, 2026, disclosing under Regulation FD that its Group CEO presented at the Barclays Global Consumer Conference via a live audio webcast on the same date.

Aakashdeep | 08 September 2026

Meshflow Acquisition Corp. Signs Business Combination Deal With HGP Intelligent Energy

Meshflow Acquisition Corp. filed a Form 8-K on September 8, 2026, disclosing that on September 5, 2026, it entered into a Business Combination Agreement with HGP Intelligent Energy, LLC, a Wyoming-based technology company focused on nuclear power plant technology.

Vinay Lochav | 08 September 2026
Support

Hi! How can we help you today?

Loading…